A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca2+ Signaling Pathway

Jingyun Liu(Dalian Medical University), Haiying Ma(Dalian Medical University)
Pharmaceuticals
November 28, 2022
Cited by 7


Related Papers